ACRO Biomedical Co., Ltd.

ACRO Biomedical develops and produces biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat and non-collagenous proteins from animal tissues, while keeping the undiminished collagen scaffold as the biomaterial for high-end medical devices in the medical regenerative field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular and neural surgery, etc.

AllisWell Bio Co., ltd.

Disposable cell culture factory, disposable cell culture erlenmeyer flask, cell freezing consumables, automated cell culture equipment, 3D bioprinting, cell culture microcarriers (dissolvable), devices for isolating single cells from tissue, cell counters...etc.

Apexcella Biomedical Inc.

Apexcella Biomedical Inc. has developed unique apexNK® cell expansion technologies, which can produce mass apexNK® cells with high purity and high cytotoxicity. Based on the technologies, the company is committed to develop innovative allogeneic apexNK® cell therapies, such as combination therapies with antibodies, and CAR-NK etc. Apxcella hopes to resolve the unmet needs and provide cancer patients the next-generation allogeneic curative cell therapies.

Biomedical EliteCell Corp.

With 10-years experiences, EliteCell aims to providing optimal cell culture solutions for a broad range of cells to support and accelerate the development of cell therapies and regenerative medicines from research to clinic.

EliteCell's cGMP-compliant facility located in Texas, USA. EliteCell supplies xenogeneic-free serum replacement, serum-free human lymphocytes culture media, primary NK culture kit to the top research and academic institutions as well as biotechnology, cell therapy, and pharmaceutical companies in worldwide.

ChainHome Biotech Inc.

1. AT M1 filling station
2. Masterflex peristaltic pump display

Gwo Xi Stem Cell Applied Technology Co., Ltd.

Gwo Xi Stem Cell Company has established the R&D center for cell therapy development since 2011. We are committed to developing stem cell medicines that have the potential to help patients with unmet medical needs. Our production platform fully comply with medical regulations (Good Tissue Practice, GTP) in Taiwan. We have three clinical trials are ongoing in Taiwan, and one clinical trial is ongoing in Vietnam by now. In the future, we will have established the PIC/S GMP grade stem cell preparation factory (15,225 m2 built-out space) in Hsinchu Biomedical Science Park in Taiwan to put stem cell-based medicinal products into practice.

Gwo Xi Stem Cell Applied Technology Co., Ltd.

Gwo Xi Stem Cell Company has established the R&D center for cell therapy development since 2011. We are committed to developing stem cell medicines that have the potential to help patients with unmet medical needs. Our production platform fully comply with medical regulations (Good Tissue Practice, GTP) in Taiwan. We have three clinical trials are ongoing in Taiwan, and one clinical trial is ongoing in Vietnam by now. In the future, we will have established the PIC/S GMP grade stem cell preparation factory (15,225 m2 built-out space) in Hsinchu Biomedical Science Park in Taiwan to put stem cell-based medicinal products into practice.

Han Biomedical Inc.

HAN Biomedical is a company devoted in R&D of Healthcare products of Advanced biomaterials to meet patients’ Needs in tissue repair and regeneration.
We develop novel, structured biomaterials for tissue regeneration to fulfill the unmet needs of patients in various tissue repair. Our team is including experienced professionals in research & design, commercialization, regulation and marketing of biomaterials.

Locus Cell Co., Ltd.

Locus Cell Co., Ltd. is a subsidiary of Metatech group company which is a contract development and manufacturing organization (CDMO) that focuses on the manufacturing of cell and gene therapy products, providing at least 15 different cell technologies, manufacture, and development services, such as chondrocyte, fibroblast, epithelial cell, iPSC-derived cell sheets, immune cell, and CAR-T, etc. Locus Cell keeps developing other derived cell technology platforms and other related products. While, Locus Cell with parent company Metatech also supply CRO services such as clinical application, program, and other corresponding services for customers or cooperative company. Located in Hsinchu Biomedical Science Park, Taiwan, where ample resources are available to foster the development of the biomedical industry such as R&D and pilot production, Locus Cell is partnered with Hitachi Group to introduce the state-of-the-art GMP manufacturing facility with more than 24 cleanrooms and advanced technology. Locus Cell aims to render services to fulfill the medical needs of advanced regenerative medicinal products worldwide.

StemCyte Taiwan Co., Ltd.

StemCyte International Ltd. is a leading Cell Therapy Company focused on developing cell therapies as drug products and providing cell therapy products and services. Our cell therapy pipeline includes several human clinical trials in spinal cord injury, long-COVID-19, acute stroke and cerebral palsy.

StemCyte holds thousands of cord blood units as the raw material for cell therapy. In the past 20 years, StemCyte has released more than 2,500 cord blood units to 350 transplant centers worldwide.